2nd Quarter - Report

REM STRATEGIES, LLC for A.P. GOLDSHIELD LLC

Period 2nd Quarter 2023 Filed Jul 19, 2023 Signed by Robert E. Mills

Official filing
Firm
REM STRATEGIES, LLC
Client
A.P. GOLDSHIELD LLC
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Continue to identify areas in healthcare sector for Goldshield technologies. Engaged FDA to identify authorization for Goldshield products for direct food contact usage on surfaces. Contact with EPA to discuss this issue as well.

LobbyistCovered position, as disclosed
ROBERT E. MILLS lobbyist, President REM Strategies LLC

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Chemicals/Chemical Industry CHM

Discussion with EPA and FDA about label claims for Goldshield antimicrobial technologies.

LobbyistCovered position, as disclosed
ROBERT E. MILLS —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Environmental Protection Agency (EPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.